Cooper; Julian D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cooper; Julian D..The latest application filed is for "lanthionine synthetase c-like 2-based therapeutics".

Company Profile

9.9.13

Cooper; Julian D. - Blacksburg VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lanthionine Synthetase C-like 2-based Therapeutics App 20210046070 - Bassaganya-Riera; Josep ; et al.	2021-02-18
Lanthionine synthetase C-like 2-based therapeutics Grant 10,849,895 - Bassaganya-Riera , et al. December 1, 2	2020-12-01
Lanthionine Synthetase C-like 2-based Therapeutics App 20200261447 - Bassaganya-Riera; Josep ; et al.	2020-08-20
Lanthionine synthetase C-like 2-based therapeutics Grant 10,682,349 - Bassaganya-Riera , et al.	2020-06-16
Lanthionine Synthetase C-like 2-based Therapeutics App 20200046694 - Bassaganya-Riera; Josep ; et al.	2020-02-13
Lanthionine synthetase C-like 2-based therapeutics Grant 10,493,072 - Bassaganya-Riera , et al. De	2019-12-03
Lanthionine Synthetase C-like 2-based Therapeutics App 20190125744 - Bassaganya-Riera; Josep ; et al.	2019-05-02
Lanthionine synthetase C-like 2-based therapeutics Grant 10,201,538 - Bassaganya-Riera , et al. Feb	2019-02-12
Lanthionine Synthetase C-like 2-based Therapeutics App 20180289703 - BASSAGANYA-RIERA; JOSEP ; et al.	2018-10-11
Lanthionine synthetase C-like 2-based therapeutics Grant 10,028,950 - Bassaganya-Riera , et al. July 24, 2	2018-07-24
Lanthionine Synthetase C-like 2-based Therapeutics App 20180055841 - Bassaganya-Riera; Josep ; et al.	2018-03-01
Lanthionine synthetase C-like 2-based therapeutics Grant 9,839,635 - Bassaganya-Riera , et al. December 12, 2	2017-12-12
Lanthionine Synthetase C-like 2-based Therapeutics App 20170119762 - Bassaganya-Riera; Josep ; et al.	2017-05-04
Lanthionine synthetase C-like 2-based therapeutics Grant 9,556,146 - Bassaganya-Riera , et al. January 31, 2	2017-01-31
Lanthionine Synthetase C-like 2-based Therapeutics App 20160115153 - Bassaganya-Riera; Josep ; et al.	2016-04-28
Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses Grant 7,888,321 - Cooper , et al. February 15, 2	2011-02-15
Transgenic Proteins From Multi-gene Systems, Methods, Compositions, Uses And The Like Relating Thereto App 20100333218 - Cooper; Julian D. ; et al.	2010-12-30
Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto Grant 7,723,563 - Cooper , et al. May 25, 2	2010-05-25
Production Of High Levels Of Transgenic Factor Ix Without Gene Rescue, And Its Therapeutic Uses App 20090239797 - COOPER; Julian D. ; et al.	2009-09-24
Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses App 20040133930 - Cooper, Julian D. ; et al.	2004-07-08
Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto App 20040133932 - Cooper, Julian D. ; et al.	2004-07-08
Production of high levels of transgenic factor VII with engineered stability and its therapeutic uses App 20040117862 - Cooper, Julian D. ; et al.	2004-06-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.